OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
OMEROS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$16.35+0.15 (+0.93%)
Close on Oct 19, 2026
- Market cap
- $1.47B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$8.25 (+101.7%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $1.47B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -4.69%
Fundamentals
- Net income
- $124.83M
- EPS, diluted
- -$0.05
- Free cash flow
- -$68.73M
- Book value per share
- -$0.57
- Diluted shares
- 90M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$72.82M
Net income
$124.83M
EPS, diluted
–
Free cash flow
-$68.73M
Reported periodTrailing twelve months